Iodine for Thyroid Function

Finding: Comprehensive synthesis confirming iodine deficiency as the leading preventable cause of intellectual disability worldwide; even mild-moderate deficiency in pregnancy is associated with reduced child IQ. Universal salt iodization is the primary public-health intervention; correction reverses goiter and overt hypothyroidism at population level. Excess iodine is also reviewed as harmful (see bidirectional caveat).

Finding: Bidirectional risk demonstrated: more-than-adequate (UIC 243) and excessive (UIC 651) iodine intake significantly increased incidence of subclinical hypothyroidism (2.6% and 6.1% vs 0.2% in mildly deficient region, p<0.001) and autoimmune thyroiditis. Mildly deficient region had higher incidence of goiter and hyperthyroidism. Conclusion: 'more than adequate or excessive iodine intake may lead to hypothyroidism and autoimmune thyroiditis.' Anchor citation for excess-iodine harm.

Finding: Acute iodine load triggers transient Wolff-Chaikoff effect (autoregulatory inhibition of thyroid hormone synthesis lasting ~24-48h); failure to escape causes iodine-induced hypothyroidism, especially in fetuses, neonates, the elderly, and patients with underlying Hashimoto's. Chronic excess can precipitate autoimmune thyroiditis (rising TPOAb) and, in iodine-deficient nodular populations, Jod-Basedow hyperthyroidism. Vulnerable subgroups: pregnancy, neonates, autoimmune thyroid disease, prior partial thyroidectomy.

Finding: 111 of 152 countries had adequate iodine intake at survey time; 30 remained deficient; 11 had excessive intake (median UIC >300 mcg/L, including parts of coastal East Asia). Reinforces that universal salt iodization works at population scale and that surveillance must monitor BOTH deficiency AND excess. Pregnant women remain a vulnerable subgroup with persistent mild deficiency in many countries deemed sufficient overall.

Finding: Number of iodine-deficient countries fell from 54 (2003) to 32 (2011); however 9 countries (including USA, Australia, UK in subgroups) shifted into mild deficiency, and several (e.g., Brazil, parts of Asia/Africa) moved into excess. Demonstrates that iodine sufficiency is a moving target requiring ongoing surveillance and that BOTH under- and over-correction are documented in real populations. Supports the bidirectional public-health framing.

Finding: Iodine intake shows a U-shaped relationship with thyroid disease: low intake increases nodular goiter and toxic nodular hyperthyroidism in older adults; replete-to-high intake increases autoimmune (Hashimoto) hypothyroidism. Following Danish mandatory iodization (raising intake from ~50 to ~100 mcg/day), incidence of hyperthyroidism initially rose (Jod-Basedow in pre-existing nodular goiter) and overt hypothyroidism subsequently increased. Confirms bidirectional caveat at the cohort level and warns against megadose correction.

Finding: ATA position: routine 150 mcg/day potassium iodide in pregnancy/lactation in non-deficient countries (Strong/Moderate). Explicit caution against megadose iodine (>500 mcg/day sustained) due to risk of fetal/neonatal hypothyroidism via Wolff-Chaikoff effect. Discourages kelp and seaweed supplements due to unpredictable iodine content. Operationalizes the bidirectional principle in clinical guidance.